No products in the cart.

CVS Health Shares Plunge 13 percent After Q1 Miss

CVS Health (NYSE:CVS) experienced a significant drop in first-quarter profits and adjusted its full-year earnings forecast, leading to a premarket share decline of over 13%. Both earnings and revenue missed Wall Street projections. Adjusted earnings per share (EPS) for the quarter came in at $1.33, well below the $1.71 consensus. Revenue for the quarter reached $88.4 billion, falling short of the estimated $89.33 billion.
While first-quarter revenue showed a 3.7% increase from the previous year, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, it was partially offset by a decline in the Health Services segment. Despite revenue growth, adjusted EPS of $1.31 represented a sharp drop from $2.20 in the previous year, mainly due to the Health Care Benefits segment’s operating results being pressured by increased usage in the Medicare business.
Looking ahead, CVS Health updated its full-year 2024 guidance, projecting a minimum adjusted EPS of $7.00, which falls short of the previous analyst consensus of $8.28. This revision reflects the company’s expectation that the utilization pressure affecting the Health Care Benefits segment will persist throughout the year.

Subscribe to get Latest News

Latest Articles

More like this